New Amsterdam Partners Boosted Its Emergent Biosolutions (EBS) Holding; Bioamber Has 0.61 Sentiment

February 15, 2018 - By Marie Mckinney

New Amsterdam Partners Llc increased Emergent Biosolutions Inc (EBS) stake by 66.28% reported in 2017Q3 SEC filing. New Amsterdam Partners Llc acquired 65,109 shares as Emergent Biosolutions Inc (EBS)’s stock declined 2.14%. The New Amsterdam Partners Llc holds 163,337 shares with $6.61 million value, up from 98,228 last quarter. Emergent Biosolutions Inc now has $2.38 billion valuation. The stock increased 0.53% or $0.25 during the last trading session, reaching $48.81. About 82,129 shares traded. Emergent BioSolutions Inc. (NYSE:EBS) has declined 23.64% since February 15, 2017 and is downtrending. It has underperformed by 40.34% the S&P500.

Bioamber Inc (BIOA) investors sentiment decreased to 0.61 in Q3 2017. It’s down -0.48, from 1.09 in 2017Q2. The ratio dropped, as 11 active investment managers increased and opened new stock positions, while 18 decreased and sold their stakes in Bioamber Inc. The active investment managers in our database now own: 7.40 million shares, down from 16.61 million shares in 2017Q2. Also, the number of active investment managers holding Bioamber Inc in top ten stock positions was flat from 0 to 0 for the same number . Sold All: 11 Reduced: 7 Increased: 7 New Position: 4.




Among 5 analysts covering Emergent Biosolutions (NYSE:EBS), 3 have Buy rating, 0 Sell and 2 Hold. Therefore 60% are positive. Emergent Biosolutions had 8 analyst reports since August 10, 2015 according to SRatingsIntel. The stock has “Buy” rating by Singular Research on Monday, March 28. Wells Fargo initiated the stock with “Outperform” rating in Friday, February 19 report. The firm earned “Hold” rating on Monday, August 10 by Zacks. Cowen & Co maintained it with “Hold” rating and $3300 target in Friday, July 14 report. Singular Research maintained it with “Buy” rating and $40 target in Tuesday, June 28 report. Chardan Capital Markets initiated the stock with “Buy” rating in Friday, April 15 report.

Since August 15, 2017, it had 0 buys, and 14 insider sales for $10.04 million activity. $311,458 worth of stock was sold by Havey Adam on Wednesday, September 27. 15,000 shares valued at $598,770 were sold by Abdun-Nabi Daniel on Wednesday, September 27. Hauer Jerome M also sold $391,787 worth of Emergent BioSolutions Inc. (NYSE:EBS) shares. $962,500 worth of Emergent BioSolutions Inc. (NYSE:EBS) shares were sold by El-Hibri Fuad. $947,240 worth of Emergent BioSolutions Inc. (NYSE:EBS) was sold by Richard Ronald on Wednesday, September 27.

Investors sentiment increased to 1.69 in Q3 2017. Its up 0.12, from 1.57 in 2017Q2. It increased, as 11 investors sold EBS shares while 48 reduced holdings. 34 funds opened positions while 66 raised stakes. 33.90 million shares or 1.32% less from 34.36 million shares in 2017Q2 were reported. Bridgeway Capital Mngmt Inc reported 0.01% of its portfolio in Emergent BioSolutions Inc. (NYSE:EBS). Fincl Bank Of Nova Scotia owns 7,200 shares. Zebra Cap Management Ltd Liability Corp holds 0.09% or 6,741 shares in its portfolio. Convergence Invest Partners Limited Liability Company holds 0.29% or 51,066 shares in its portfolio. Chicago Equity Partners stated it has 46,365 shares or 0.06% of all its holdings. Us National Bank & Trust De reported 37,498 shares stake. Zurcher Kantonalbank (Zurich Cantonalbank) holds 1,409 shares or 0% of its portfolio. Thrivent Financial For Lutherans has invested 0% in Emergent BioSolutions Inc. (NYSE:EBS). Credit Suisse Ag stated it has 43,681 shares. Kennedy Cap Management Inc owns 233,542 shares. Jpmorgan Chase & Com accumulated 13,488 shares. Employees Retirement Sys Of Texas holds 0.06% of its portfolio in Emergent BioSolutions Inc. (NYSE:EBS) for 116,000 shares. Manufacturers Life Ins The owns 649,220 shares or 0.03% of their US portfolio. Ls Inv Advisors Ltd Liability reported 0% in Emergent BioSolutions Inc. (NYSE:EBS). State Of Alaska Department Of Revenue holds 6,911 shares or 0.01% of its portfolio.

New Amsterdam Partners Llc decreased Ilg Inc stake by 150,958 shares to 491,326 valued at $13.13 million in 2017Q3. It also reduced United Rentals Inc (NYSE:URI) stake by 3,273 shares and now owns 48,148 shares. Ubiquiti Networks Inc (NASDAQ:UBNT) was reduced too.

BioAmber Inc., an industrial biotechnology company, produces and sells bio-succinic acid to various chemical market clients primarily in the United States and Canada. The company has market cap of $5.05 million. The Company’s proprietary technology platform combines industrial biotechnology and chemical catalysis to convert renewable feedstocks into chemicals that are replacements for petroleum-derived chemicals. It currently has negative earnings. The companyÂ’s bio-succinic acid is used in various applications, including plasticizers, polyurethanes, personal care products, resins and coatings, de-icing solutions, PET resins, lubricants, polybutylene succinate, fine chemicals, and food additives.

The stock decreased 9.92% or $0.0066 during the last trading session, reaching $0.0599. About 2.19 million shares traded or 36.91% up from the average. BioAmber Inc. (BIOA) has declined 32.24% since February 15, 2017 and is downtrending. It has underperformed by 48.94% the S&P500.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: